Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells

Lou,Chenghua; Zhu,Zhihui; Zhao,Yaping; Zhu,Rui; Zhao,Huajun

doi:10.3892/or.2016.5269

Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells

Authors:
- Chenghua Lou
- Zhihui Zhu
- Yaping Zhao
- Rui Zhu
- Huajun Zhao
View Affiliations

Affiliations: College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Binjiang, Hangzhou, Zhejiang 310053, P.R. China
Published online on: November 23, 2016 https://doi.org/10.3892/or.2016.5269
Pages: 179-184

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Arctigenin is a bioactive lignan isolated from the seeds of Arctium lappa L. which has been widely used as a diuretic and a diaphoretic in Traditional Chinese Medicine. In the present study, the authors investigated the effects of arctigenin on tumor migration and invasion in aggressive human breast cancer cells. The MTT assay results showed that arctigenin did not show a significant cytotoxic effect on the cell viability of MDA-MB-231 cells. However, wound healing migration and Boyden chamber invasion assays demonstrated that arctigenin significantly inhibited in vitro migration and invasion of the MDA-MB-231 cells. Furthermore, gelatin zymography results showed that arctigenin reduced the activity of MMP-2 and MMP-9. Western blot analysis results demonstrated that the expression of MMP-2, MMP-9 and heparanase proteins was significantly downregulated following the treatment of arctigenin. Finally, the antiangiogenic activity of arctigenin was also examined by the chick embryo chorioallantoic membrane (CAM) assay. Arctigenin treatment significantly inhibited angiogenesis in the CAM. In conclusion, the results revealed that arctigenin significantly inhibited the migration and invasion of MDA-MB-231 cells by downregulating MMP-2, MMP-9 and heparanase expression. However, further studies are still necessary to investigate the exact mechanisms involved and to explore signal transduction pathways to better understand the biological mechanisms.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Louie E, Chen XF, Coomes A, Ji K, Tsirka S and Chen EI: Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis. Oncogene. 32:4064–4077. 2013. View Article : Google Scholar : PubMed/NCBI
3	Coleman RE: Metastatic bone disease: Clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 27:165–176. 2001. View Article : Google Scholar : PubMed/NCBI
4	Mann J: Natural products in cancer chemotherapy: Past, present and future. Nat Rev Cancer. 2:143–148. 2002. View Article : Google Scholar : PubMed/NCBI
5	Crowell JA: The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: An overview. Eur J Cancer. 41:1889–1910. 2005. View Article : Google Scholar : PubMed/NCBI
6	Knipping K, van Esch EC, Wijering SC, van der Heide S, Dubois AE and Garssen J: In vitro and in vivo anti-allergic effects of Arctium lappa L. Exp Biol Med. 233:1469–1477. 2008. View Article : Google Scholar
7	Sun Q, Liu K, Shen X, Jin W, Jiang L, Sheikh MS, Hu Y and Huang Y: Lappaol F, a novel anticancer agent isolated from plant Arctium lappa L. Mol Cancer Ther. 13:49–59. 2014. View Article : Google Scholar : PubMed/NCBI
8	Wang Z, Li P and Wang C, Jiang Q, Zhang L, Cao Y, Zhong W and Wang C: Protective effects of Arctium lappa L. root extracts (AREs) on high fat diet induced quail atherosclerosis. BMC Complement Altern Med. 16:62016.
9	Herrmann F, Romero MR, Blazquez AG, Kaufmann D, Ashour ML, Kahl S, Marin JJG, Efferth T and Wink M: Diversity of pharmacological properties in Chinese and European medicinal plants: Cytotoxicity, antiviral and antitrypanosomal screening of 82 herbal drugs. Diversity. 3:547–580. 2011. View Article : Google Scholar
10	Cho MK, Jang YP, Kim YC and Kim SG: Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: The role in TNF-alpha inhibition. Int Immunopharmacol. 4:1419–1429. 2004. View Article : Google Scholar : PubMed/NCBI
11	Zhang WZ, Jiang ZK, He BX and Liu XB: Arctigenin protects against lipopolysaccharide-induced pulmonary oxidative stress and inflammation in a mouse model via suppression of MAPK, HO-1, and iNOS signaling. Inflammation. 38:1406–1414. 2015. View Article : Google Scholar : PubMed/NCBI
12	Li W, Zhang Z, Zhang K, Xue Z, Li Y, Zhang Z, Zhang L, Gu C, Zhang Q, Hao J, et al: Arctigenin suppress Th17 cells and ameliorates experimental autoimmune encephalomyelitis through AMPK and PPAR-gamma/ROR-gammat signaling. Mol Neurobiol. 53:5356–5366. 2016. View Article : Google Scholar : PubMed/NCBI
13	Hayashi K, Narutaki K, Nagaoka Y, Hayashi T and Uesato S: Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus. Biol Pharm Bull. 33:1199–1205. 2010. View Article : Google Scholar : PubMed/NCBI
14	Susanti S, Iwasaki H, Itokazu Y, Nago M, Taira N, Saitoh S and Oku H: Tumor specific cytotoxicity of arctigenin isolated from herbal plant Arctium lappa L. J Nat Med. 66:614–621. 2012. View Article : Google Scholar : PubMed/NCBI
15	Lou C, Takahashi K, Irimura T, Saiki I and Hayakawa Y: Identification of Hirsutine as an anti-metastatic phytochemical by targeting NF-κB activation. Int J Oncol. 45:2085–2091. 2014.PubMed/NCBI
16	El-Rifai W and Powell SM: Molecular biology of gastric cancer. Semin Radiat Oncol. 12:128–140. 2002. View Article : Google Scholar : PubMed/NCBI
17	Li ZH and Yang SM: Research advancement on heparanase in tumor metastasis. Ai Zheng. 24:1156–1160. 2005.(In Chinese). PubMed/NCBI
18	Ilan N, Elkin M and Vlodavsky I: Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol. 38:2018–2039. 2006. View Article : Google Scholar : PubMed/NCBI
19	Hoffmann AC, Mori R, Vallbohmer D, Brabender J, Drebber U, Baldus SE, Klein E, Azuma M, Metzger R, Hoffmann C, et al: High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF. J Gastrointest Surg. 12:1674–1682. 2008. View Article : Google Scholar : PubMed/NCBI
20	Ribatti D: Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. Int Rev Cell Mol Biol. 270:181–224. 2008. View Article : Google Scholar : PubMed/NCBI
21	Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 29:(Suppl 16). S15–S18. 2002. View Article : Google Scholar
22	Geiger TR and Peeper DS: Metastasis mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
23	Gupta GP and Massagué J: Cancer metastasis: Building a framework. Cell. 127:679–695. 2006. View Article : Google Scholar : PubMed/NCBI
24	Meadows GG: Diet, nutrients, phytochemicals, and cancer metastasis suppressor genes. Cancer Metastasis Rev. 31:441–454. 2012. View Article : Google Scholar : PubMed/NCBI
25	Sani IK, Marashi SH and Kalalinia F: Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity. Toxicol In Vitro. 29:893–900. 2015. View Article : Google Scholar : PubMed/NCBI
26	Machado FB, Yamamoto RE, Zanoli K, Nocchi SR, Novello CR, Schuquel IT, Sakuragui CM, Luftmann H, Ueda-Nakamura T, Nakamura CV, et al: Evaluation of the antiproliferative activity of the leaves from Arctium lappa by a bioassay-guided fractionation. Molecules. 17:1852–1859. 2012. View Article : Google Scholar : PubMed/NCBI
27	Li QC, Liang Y, Tian Y and Hu GR: Arctigenin induces apoptosis in colon cancer cells through ROS/p38MAPK pathway. J BUON. 21:87–94. 2016.PubMed/NCBI
28	Wang P, Phan T, Gordon D, Chung S, Henning SM and Vadgama JV: Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells. Mol Nutr Food Res. 59:250–261. 2015. View Article : Google Scholar : PubMed/NCBI
29	Huang K, Li LA, Meng YG, You YQ, Fu XY and Song L: Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling. Basic Clin Pharmacol Toxicol. 115:507–511. 2014. View Article : Google Scholar : PubMed/NCBI
30	Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K and Takano Y: Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res. 26:3579–3583. 2006.PubMed/NCBI
31	Bae MJ, Karadeniz F, Lee SG, Seo Y and Kong CS: Inhibition of MMP-2 and MMP-9 activities by Limonium tetragonum extract. Prev Nutr Food Sci. 21:38–43. 2016. View Article : Google Scholar : PubMed/NCBI
32	Chandler S, Miller KM, Clements JM, Lury J, Corkill D, Anthony DC, Adams SE and Gearing AJ: Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview. J Neuroimmunol. 72:155–161. 1997. View Article : Google Scholar : PubMed/NCBI
33	Overall CM and López-Otín C: Strategies for MMP inhibition in cancer: Innovations for the post-trial era. Nat Rev Cancer. 2:657–672. 2002. View Article : Google Scholar : PubMed/NCBI
34	Kong CS, Kim YA, Kim MM, Park JS, Kim JA, Kim SK, Lee BJ, Nam TJ and Seo Y: Flavonoid glycosides isolated from Salicornia herbacea inhibit matrix metalloproteinase in HT1080 cells. Toxicol In Vitro. 22:1742–1748. 2008. View Article : Google Scholar : PubMed/NCBI
35	Shteingauz A, Boyango I, Naroditsky I, Hammond E, Gruber M, Doweck I, Ilan N and Vlodavsky I: Heparanase enhances tumor growth and chemoresistance by promoting autophagy. Cancer Res. 75:3946–3957. 2015. View Article : Google Scholar : PubMed/NCBI
36	Tang D, Piao Y, Zhao S, Mu X, Li S, Ma W, Song Y, Wang J, Zhao W and Zhang Q: Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer. Med Oncol. 31:262014. View Article : Google Scholar : PubMed/NCBI
37	Chen Y, Chen Y, Huang L and Yu J: Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma. J Dermatol. 39:339–343. 2012. View Article : Google Scholar : PubMed/NCBI